Corum Group Limited
COO.AX
Australian Securities Exchange0.04
AUD
+0.00
- -
Corum Group Limited
COO.AX
(Australian Securities Exchange)
Recent
price
0.04
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Corum Group Limited (ASX:COO) is an Australian technology company that develops and provides software solutions primarily for the community pharmacy sector and electronic commerce transactions. The company offers pharmacy management software including dispensing systems such as Corum Clear Dispense, Corum LOTS Dispense and Corum ScriptArc for script management; point-of-sale (POS) systems; head office software for managing multiple pharmacy stores with features like group ordering, stock management and sales monitoring; and the PharmX ordering platform, an electronic gateway connecting nearly all Australian pharmacies to wholesalers and suppliers, complemented by the commission-based PharmXchange platform launched in 2022 for expanded payment and ordering capabilities. Through Corum eCommerce, it operates a financial payment gateway supporting electronic bill payments and funds transfers for councils, real estate firms and corporate clients; Corum Real Estate Services provides rental solutions including the SwiftRent mobile app; and additional services encompass secure backup solutions, support and hardware for pharmacy operations. Founded prior to its ASX listing in 1971 and headquartered in Sydney, New South Wales, Corum Group focuses on the Australian market with a single reporting segment in pharmacy software and technology, serving independent pharmacies, pharmacy groups and related wholesalers. Recent developments include the commercial rollout of Corum Clear Dispense as a next-generation platform noted for its intuitive design and speed, ongoing expansion of PharmXchange which had secured approximately 25% of Australian pharmacies and major suppliers like Blackmores, Haleon and Revlon by early 2023, and strategic considerations for divesting non-core software assets alongside capital management initiatives such as potential acquisitions or share buybacks supported by excess cash.